Associated Papers
Domain-Specific Impacts of Spike Protein Mutations on Infectivity and Antibody Escape in SARS-CoV-2 Omicron BA.1.
Kim TH et al.
Journal of Microbiology and Biotechnology, 2025
Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization.
Pastorio C et al.
Iscience, 2023
Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion.
Lubin JH et al.
Jci Insight, 2023
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Huo J et al.
Cell Reports, 2023
Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice.
Liu S et al.
Cell Reports, 2022
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.
Naaber P et al.
Cell Reports. Medicine, 2022
35952669 (PubMed )
Supplement: mmc2.pdf
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study.
Sheward DJ et al.
The Lancet. Infectious Diseases, 2022
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yahalom-Ronen Y et al.
Vaccines, 2022
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
Clark SA et al.
Cell, 2021
Select a paper to view details